The Skylife™ Neonatal Phototherapy System provides advanced technology for newborn jaundice treatment and hyperbilirubinemia management. Its innovative 3D Light Array, powered by its revolutionary Spectral Power Treatment™, bathes neonates in a gentle yet highly effective light, featuring a narrow bandwidth of light between 430-475nm to align with the bilirubin absorption spectrum, ensuring effective treatment.

Exceeding the American Academy of Paediatrics guidelines, the system delivers uniform light distribution with three adjustable irradiance levels. With up to 40% body coverage (119 in² / 769 cm²), it ensures efficient and effective treatment for neonatal jaundice.

For added patient comfort, Skylife’s under-baby system with the easy-to-clean GelMat minimises pressure points, bringing the light closer to the baby and increasing irradiance for more effective treatment. Its open design provides an unobstructed view and simple patient access, ensuring ease of use for healthcare professionals while offering reassurance to parents and guardians.
 

Key Features

Spectral Power Treatment™: 
Delivers light within a narrow bandwidth of 430-475 nm, closely matching the bilirubin absorption spectrum for effective jaundice management. 

Adjustable Irradiance Levels: 
Provides three settings—Low (30 ± 5 μW/cm²/nm), High (45 ± 10 μW/cm²/nm), and Very High (>55 μW/cm²/nm)—allowing clinicians to tailor treatment intensity to individual patient needs. 

3D Light Array™: 
Achieves up to 40% body surface coverage with uniform light distribution, promoting treatment efficiency. 

Under-Baby Design with GelMat: 
Positions the light source beneath the infant, bringing it closer to the skin to increase irradiance. The GelMat provides comfort by alleviating pressure points. 

Portability: 
Weighing less than 4.5 kg, Skylife is ergonomically designed for easy transport between beds, making it suitable for various neonatal care settings.